David Martin

David Martin

Ask VT AI
View News Summary
  • Hershey beats Q3 expectations, raises 2025 outlook despite higher costs and a slower start to the Halloween season.
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
  • SNAP benefits in limbo as courts and officials clash over funding, leaving millions of recipients uncertain about November payments.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Hershey beats Q3 expectations, raises 2025 outlook despite higher costs and a slower start to the Halloween season.
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
  • SNAP benefits in limbo as courts and officials clash over funding, leaving millions of recipients uncertain about November payments.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from David Martin